Elsevier Announces Availability of Urban & Fischer Journal Archives on SciVerse ScienceDirect

Amsterdam, November 1, 2011 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the availability of  Elsevier Urban & Fischer Journal Archives, three new backfile collections in the life and health sciences, on  SciVerse ScienceDirect.

The new backfiles, published in English under the renowned German imprint Urban & Fischer, contain journals concerning immunology and microbiology, medicine, and biochemistry (the biochemistry collection is scheduled for release in mid-November). The archives extend from1970, when the articles were first published in English, to 2000 and seamlessly link to volumes starting from 2001 already available on SciVerse ScienceDirect.

"Foundational discoveries by German scientists have made significant contributions to today’s global research landscape,” said Bas Straub, Publishing Director, Elsevier. “These new archives support both research and teaching. Through these archives, the discovery of the past will enable researchers and teachers to explore the historical precedents that influence the science of today and tomorrow.” 

###
 

About SciVerse ScienceDirect
SciVerse ScienceDirect ( www.sciverse.com) contains over a quarter of the world's full text scientific, technical and medical (STM) peer-reviewed articles - managed by renowned editors, written by respected authors and read by researchers from around the globe. Elsevier's extensive full-text collection covers authoritative titles from the core scientific literature with more than ten million articles available online. Coverage includes over 2,500 journal titles published by Elsevier with dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. Additionally, SciVerse ScienceDirect contains an expanding library of online major reference works, handbooks, book series and over 10,000 eBooks in all fields of science seamlessly interlinked with primary research referenced in journal articles.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact 
Will DeGirolamo
+1 212-752-8338
wdegirolamo@padillaspeer.com